Oaktree Acquisition Corp. III Life Sciences (OACCU) — 10-Q Filings
All 10-Q filings from Oaktree Acquisition Corp. III Life Sciences. Browse 3 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (3)
-
Oaktree SPAC Swings to Profit on Trust Account Interest
— Nov 13, 2025 Risk: medium
Oaktree Acquisition Corp. III Life Sciences (OACCU) reported a net income of $1,966,742 for the three months ended September 30, 2025, a significant improvement -
Oaktree SPAC Posts Q2 Profit from Trust Account Interest
— Aug 12, 2025 Risk: high
Oaktree Acquisition Corp. III Life Sciences (OACCU) reported a net income of $1,874,343 for the three months ended June 30, 2025, and $3,533,134 for the six mon -
Oaktree Acquisition Corp. III Life Sciences Q1 2025 10-Q Filed
— May 14, 2025 Risk: medium
Oaktree Acquisition Corp. III Life Sciences filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX